SONN icon

Sonnet BioTherapeutics

21 hedge funds and large institutions have $1.57M invested in Sonnet BioTherapeutics in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.

Holders
21
Holders Change
+4
Holders Change %
+23.53%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
5
Reduced
4
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TDC
1
Thompson Davis & Co
Virginia
$381K 381,643 +21,500 +6%
Bank of America
2
Bank of America
North Carolina
$253K 252,828 -20,000 -7%
Vanguard Group
3
Vanguard Group
Pennsylvania
$218K 217,873 +9,009 +4%
IC
4
Intersect Capital
California
$124K 123,783
BIT
5
BlackRock Institutional Trust
California
$101K 101,212
Geode Capital Management
6
Geode Capital Management
Massachusetts
$92K 92,136
Morgan Stanley
7
Morgan Stanley
New York
$88K 88,080 +88,080 New
EVC
8
Eidelman Virant Capital
Missouri
$84K 85,000 +5,000 +6%
GHAM
9
Gilman Hill Asset Management
Connecticut
$60K 59,890 +11,556 +24%
CDH
10
Charles D. Hyman
$44K 44,444
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$24K 23,952 -41,900 -64%
CL
12
CSS LLC
Illinois
$22K 22,728
Goldman Sachs
13
Goldman Sachs
New York
$19K 18,943 +18,943 New
Northern Trust
14
Northern Trust
Illinois
$18K 17,646
TSS
15
Two Sigma Securities
New York
$16K 16,121 +2,547 +19%
VKH
16
Virtu KCG Holdings
New York
$12K 12,058 -48,903 -80%
BFA
17
BlackRock Fund Advisors
California
$4K 4,250 +4,250 New
BIM
18
BlackRock Investment Management
Delaware
$3K 3,485 -1,138 -25%
CG
19
Cutler Group
California
$3K 3,252 +3,252 New
IA
20
IFP Advisors
Florida
$2K 2,000 +2,000 New
Millennium Management
21
Millennium Management
New York
-206,219 Closed
UBS Group
22
UBS Group
Switzerland
-509 Closed
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$0 16 +16 New